Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Ackermann Michael
Director at Tarsus Pharmaceuticals. Filing since 5 Aug 2021.
CIK 0001791249
Company
Date
Role
Action
Shares
Amount
Of holding
TARS
Tarsus Pharmaceuticals, Inc.
5 May 2022
Director
Bought
100,000
$1.35M
opened
TARS
Tarsus Pharmaceuticals, Inc.
1 Dec 2021
Director
Sold, plan not stated
5,833
$143.93K
0.5%
TARS
Tarsus Pharmaceuticals, Inc.
1 Nov 2021
Director
Sold, plan not stated
5,833
$162.29K
0.5%
TARS
Tarsus Pharmaceuticals, Inc.
12 Oct 2021
Director
Sold, plan not stated
5,633
$148.00K
0.5%
TARS
Tarsus Pharmaceuticals, Inc.
8 Oct 2021
Director
Sold, plan not stated
200
$5.01K
0.0%
TARS
Tarsus Pharmaceuticals, Inc.
1 Sep 2021
Director
Sold, plan not stated
5,833
$147.24K
0.5%
TARS
Tarsus Pharmaceuticals, Inc.
11 Aug 2021
Director
Sold, plan not stated
621
$15.62K
0.1%
TARS
Tarsus Pharmaceuticals, Inc.
9 Aug 2021
Director
Sold, plan not stated
700
$17.50K
0.1%
TARS
Tarsus Pharmaceuticals, Inc.
6 Aug 2021
Director
Sold, plan not stated
3,129
$78.23K
0.3%
TARS
Tarsus Pharmaceuticals, Inc.
5 Aug 2021
Director
Sold, plan not stated
1,383
$34.58K
0.1%
10 decisions on file.
